Features
Pricing
Newsletter
Events
Partners
Features
Pricing
Newsletter
Events
Partners
Loading organizations...
CAM Capital: Funding, Team & Investors | Startup Intros
Home
/
Organizations
/
CAM Capital
CAM Capital
Active
Website
Follow
Copy .md
Share
Post on X
Post on LinkedIn
Share on Reddit
Share on WhatsApp
Share on Telegram
Send an Email
Updated:
Apr 2, 2026
·
Suggest an edit
About
News
Financials
Team
Deep Dive
FAQs
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at CAM Capital.
BK
Bruce Kovner
Chairman
SM
Scott Morenstein
Managing Director
Leadership Team
Key people at CAM Capital.
BK
Bruce Kovner
Chairman
Scott Morenstein
Managing Director
Financial History
Total Raised
N/A
Valuation
N/A
Investments Made
Date
Company
Round
Lead Investor(s)
Co-Investor(s)
Aug 1, 2023
Kyverna Therapeutics
$60.0M Series B
Bain Capital Life Sciences
, Craig Gordon
Access Biotechnology
,
Northpond Ventures
,
venBio
,
Westlake Village BioPartners
, Sean Harper
,
Gilead Sciences
,
Insight Partners
,
jVen Capital
,
LYFE Capital
,
RTW Investments
,
Vida Ventures
May 16, 2022
Kriya Therapeutics
$270.0M Series C
Jim Momtazee
Bluebird Ventures
,
Dexcel Pharma
,
Foresite Capital
, JDRF T1D Fund
,
Lightswitch Capital
,
Narya Capital
,
QVT
,
Transhuman Capital
Jan 10, 2022
AvengeBio
$45.0M Series A
Ben Askew
,
CAM Capital
, Perceptive Xontogeny Venture Fund
Josh Richardson
,
Pappas Capital
,
Rock Springs Capital
Jan 1, 2022
Kyverna Therapeutics
$85.0M Series B
Northpond Ventures
Access Biotechnology
,
venBio
,
Westlake Village BioPartners
, Sean Harper
,
Argentum Capital Partners
, Mark Genovese
, HealthCor
,
Hudson Bay Capital
,
Insight Partners
,
Intellia Therapeutics
,
jVen Capital
,
LYFE Capital
, Niu (Chris) Liu
, Fred Cohen
Nov 1, 2021
Antios Therapeutics
$75.0M Series B
EPIQ Capital Group
, Craig Gordon
Domain Associates
,
Pontifax Venture Capital
,
Adage Capital Management
, Aisling Capital
,
Altium Capital
, Amzak Health
,
Avego Bioscience Capital
,
Delos Capital
,
Granite Point Capital
,
GRA Venture Fund
,
Heartland Healthcare Capital
,
LifeSci Venture Partners
,
Lumira Ventures
, RA Capital Management
,
Sixty Degree Capital
,
Soleus Capital
Sep 1, 2021
LEXEO Therapeutics
$100.0M Series B
Daniel Saul Sundheim
, Joy Ghosh
Omega Funds
,
Alexandria Venture Investments
,
Gray's Creek Capital Partners
,
Invus
, Janus Henderson Investors
,
Laurion Capital Management
,
Longitude Capital
,
Lundbeckfond Ventures
, PBM Capital
,
Verition Fund Management
,
Woodline Partners
Jul 14, 2021
Kriya Therapeutics
$100.0M Series B
Jim Momtazee
Alumni Ventures
,
Amplo
,
Bluebird Ventures
,
Dexcel Pharma
,
Foresite Capital
,
Hongkou
, JDRF
,
Narya Capital
,
QVT
,
Transhuman Capital
,
Woodline Partners
Apr 1, 2021
AltruBio
$63.0M Series A
—
aMoon Fund
, BVF Partners
Apr 1, 2021
Arcellx
$120.0M Series C
Samsara BioCapital
,
CAM Capital
Genoa Ventures
,
Adage
,
Asymmetry Ventures
,
CaaS Capital Management
,
Cambrian Biopharma
,
LG Tech
,
NEA
, Novo Holdings
,
Sixty Degree Capital
,
SR One
, Surveyor Capital
,
Suvretta Capital Management
,
Takeda Ventures
,
Terra Magnum Capital Partners
Apr 1, 2021
Antios Therapeutics
$96.0M Series B
Guy Levy
Domain Associates
, Michele Park
,
Pontifax Venture Capital
,
Sanofi Ventures
,
Adage Capital Management
, Aisling Capital
, Amzak Health
,
Delos Capital
,
Granite Point Capital
,
LifeSci Venture Partners
,
Lumira Ventures
, RA Capital Management
,
Sixty Degree Capital
Oct 1, 2020
Primmune Therapeutics
$27.0M Series A
CAM Capital
, Amir Nashat
Domain Associates
,
Polaris Partners
,
BioBrit
,
BioRock Ventures
,
McDermott
, Andrew Rubinstein
,
Samsara BioCapital
May 1, 2020
Palvella Therapeutics
$45.0M Series C
—
Samsara BioCapital
,
Adams Street Partners
,
Agent Capital
,
BioAdvance
, BVF Partners
, Scott Morenstein
,
Ligand Pharmaceuticals
, Sean Nolan
,
Opaleye Management
Mar 2, 2020
Primmune Therapeutics
$7.0M Seed
—
Charlie Mcdermott
,
BioBrit
,
BioRock Ventures
, Scott Morenstein
Apr 25, 2019
Satsuma Pharmaceuticals
$62.0M Series B
Wellington Management
Cormorant Asset Management
,
Eventide Asset Management
,
Lumira Ventures
,
Osage University Partners
, RA Capital Management
,
SBI Investment
,
SNBL
, Surveyor Capital
, TPG Biotech
Apr 1, 2016
Kala Pharmaceuticals
$68.0M Series C
Gregory Grunberg, M.D.
5AM Ventures
, Dave Maki
,
ARCH Venture Partners
,
Atlas Venture
,
Polaris Partners
,
CVF
,
Lux Capital
, Jonathan Silverstein
,
Polaris Partners
, Rajeev Shah
, Chen Yu
,
Wellington Management
Dec 1, 2015
Velicept Therapeutics
$21.0M Series B
Scott Morenstein
, David Hirsch
—